Text

Export License Issued to Cambridge Isotope Laboratories, Inc. XMAT451 (Public)
	ML19217A283
Person / Time
Site:	11006352
Issue date:	08/02/2019
From:	Peter Habighorst; NRC/OIP
To:	Ionta G; Cambridge Isotope Labs
	Savoy J
References
	Download: ML19217A283 (3)
	v • d • e

United States of America Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the Nuclear Regulatory Commission (NRC) issued pursuant thereto, and in reliance on the statements and representations herefore made by the licensee, a license is hereby issued to the licensee authorizing the export of the materials and/or production or utilization facilities listed below, subject to the terms and conditions herein.

NRC LICENSE NO.: XMAT451 Page 1 of 3 NRC DOCKET NO.: 11006352 LICENSE EXPIRES: April 01, 2024 Nuclear Regulatory Commission Washington, D.C. 20555 EXPORT LICENSE Cambridge Isotope Laboratories, Inc.

50 Frontage Road Andover, MA 01810 LICENSEE ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES)

INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES)

OTHER U.S. PARTY(IES) TO EXPORT Neither this license nor any right under this license shall be assigned or otherwise transferred in violation of the provisions of the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974.

This license is subject to the right of recapture or control by Section 108 of the Atomic Energy Act of 1954, as amended, and to all the other provisions of said Acts, now or hereafter in effect and to all valid rules and regulations of the NRC.

THIS LICENSE IS INVALID UNLESS SIGNED BELOW BY AUTHORIZED NRC REPRESENTATIVE NAME AND TITLE:

DATE OF ISSUANCE:

APPLICANT'S

REFERENCE:

Application Dated 3/27/2019 ULTIMATE DESTINATION: United Arab Emirates Attn: Gary Ionta QUANTITY(IES)

SIGNATURE:

10,000 kilograms See following page(s)

See following page(s)

Cambridge Istopoe Laboratories, Inc.

50 Frontage Road MA 01810 (supplier/distributor)

EXPORT LICENSE Peter J. Habighorst, Acting Deputy Director Office of International Programs DESCRIPTION OF MATERIAL(S) OR FACILITY(IES)

Deuterium in the form of deuterium oxide, deuterium gas, and other compounds.

August 02, 2019 Peter J. Habighorst Digitally signed by Peter J.

Habighorst Date: 2019.08.02 11:16:21 -04'00'

XMAT451 Page 2 of 3 ULTIMATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):

1.

(for non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

2.

(for non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

3.

(for non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

4.

(for non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

5.

(for non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

6.

(for non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

INTERMEDIATE CONSIGNEE(S) IN FOREIGN COUNTRY(IES):

1.